With better data, powerful genomic tools, and a rich cultural awareness of the c...
A hospital nonprofit formed to deal with drug shortages, Civica Rx, is consideri...
John Green, a novelist and popular YouTuber, is once again leveraging his star p...
Although much about ME/CFS is still not well-understood, decades of experience a...
“It’s like a light wind blowing in favor of patisiran over placebo,” said David ...
President Biden’s latest Cancer Moonshot efforts are inspiring hope among cancer...
Akili's move from prescription to OTC sales for its ADHD therapy signifies a maj...
A new bill seeks to have the FDA and the U.S. Patent Office coordinate efforts t...
A groundbreaking clause in a deal between the Department of Health and Human Ser...
Menarini Asia-Pacific has entered a long-term exclusive agreement to license Ast...
Dewpoint Therapeutics entered a collaboration with Chemify to expedite the disco...
The company will divest the AVTX-800 rare disease compound series to AUG Therape...
Currently, NSCLC patients with EGFR exon 19 deletions or L858R substitution face...
On August 28, the FDA approved the label expansion of Bristol Myers Squibb’s Reb...
The FDA is also reviewing a subcutaneous formulation of Takeda’s blockbuster dru...
The US Food and Drug Administration has sent letters to eight companies for unau...
